New York, New York (PRWEB) April 25, 2014
As Mirena IUD lawsuits (http://www.themirenalawsuitcenter.com)
continue to mount in courts around the country, Bernstein Liebhard LLP notes the publication of a Newsweek report that discusses many of the important issues raised by women who have filed these claims. Among other things, the April 24th article details one Mirena lawsuit plaintiff who allegedly suffered organ damage, scarring, uterine perforation and other Mirena complications after her device spontaneously migrated and became lodged in her abdominal wall. The 24-year-old woman has been forced to endure four surgeries to remove scar tissue, as well as a hysterectomy that left her infertile, according to the report.*
“Our Firm is representing a number of women in Mirena IUD lawsuits who have allegedly suffered injuries similar to those described by Newsweek,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Mirena lawsuit evaluations to women who may have been injured due to the spontaneous migration of their IUD.
Mirena IUD Lawsuits
The Mirena IUD was cleared for sale by the U.S. Food & Drug Administration (FDA) in 2000, and is now approved as a long-acting method of birth control, and as a treatment for heavy menstrual bleeding in women who wish to use an IUD as their primary method of contraception. According to a report that aired on 7 Action News this past summer, the FDA has since received more than 70,000 complaints involving Mirena complications, including thousands that detail cases of device dislocation and uterine perforation.** In 2009, the agency issued a Warning Letter to Bayer Healthcare Pharmaceuticals after finding that one of the company’s Mirena promotions made misleading claims about the safety and efficacy of the IUD.
Court documents indicate that more than 1,200 Mirena lawsuits have been filed in courts around the country on behalf of women who were allegedly injured due to spontaneous migration of the IUD. These include more than 700 lawsuits that have been filed in New Jersey’s Bergen County Superior Court, where cases have been consolidated in a multicounty litigation. (In Re: Mirena Litigation; Case No. 297) In addition to the New Jersey litigation, nearly 500 additional Mirena lawsuits that raise similar allegations have been consolidated for pretrial proceedings in the U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)
According to court records, the claims pending in these two proceedings all put forth similar allegations regarding the Mirena IUD’s potential to migrate from its proper position in the uterus following correct insertion by a healthcare provider. Among other things, plaintiffs claim that Bayer Healthcare Pharmaceuticals failed to provide adequate warnings regarding the possibility of Mirena migration, and point out that the IUD’s label only states that migration may occur if the uterus is punctured during insertion.
Women who allegedly suffered serious Mirena complications due to spontaneous migration of their IUD may be entitled to file their own claim against Bayer Healthcare Pharmaceuticals. To learn more about the ongoing Mirena litigation, visit Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/mirenalawsuithelp. For a free legal consultation, please call 800-511-5092.
*newsweek.com/2014/05/02/courtroom-controversy-behind-popular-contraceptive-mirena-248443.html, April 24, 2014
**wxyz.com/dpp/news/local_news/investigations/thousands-of-women-complain-about-dangerous-complications-from-mirena-iud-birth-control, 7 Action News, August 27, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com